Drug Trial Radar · NCT07080385
Pharmacokinetics, Efficacy, and Safety of Encaleret in Pediatric Participants With Autosomal Dominant Hypocalcemia Type 1 (ADH1)
Last checked: Nov 20, 2026Latest source record: Apr 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
28
Planned (sponsor's estimate)
Start
Jan 30, 2026
Primary completion
Dec 2028
Study completion Dec 2030
Sponsor
- Lead sponsor
- Calcilytix Therapeutics, Inc., a BridgeBio companyIndustry
- Sponsor type
- Industry
- First posted
- Jul 23, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Not applicable (single group)
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 0 years, up to 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The overall objective of this study is to evaluate the pharmacokinetics (PK), efficacy, and safety of encaleret in pediatric participants from birth to 17 years of age with ADH1.
Conditions
- Autosomal Dominant Hypocalcemia Type 1 (ADH1)
Interventions
EncaleretDrug
Oral tablets, age-appropriate pediatric formulation (currently under development).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Period 1: Maximum Plasma Concentration (Cmax) of Encaleret and Metabolites M1, and M3Time frame: 5 days
- Period 1: Area Under the Plasma Concentration-time Curve (AUC) of Encaleret and Metabolites M1, and M3Time frame: 5 days
- Period 3: Number of Participants with Albumin-corrected Blood Calcium (cCa) and Urinary Calcium (UCa) Excretion ResponseTime frame: Week 25
Locations
6 sites in 2 countries. Site status is shown where the registry gives one.
Yale University
New Haven, Connecticut · Recruiting
Children's National Medical Center
Washington D.C., District of Columbia · Recruiting
Nemours Children's Health
Jacksonville, Florida · Recruiting
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania · Recruiting
Royal London Hospital
London, United Kingdom · Recruiting
Royal Manchester Children's Hospital
Manchester, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.